Deniz 2011

Methods	RCT Method of randomisation: not described Blinding of outcome assessors: yes Adverse events: not stated Deaths: none Drop outs: none ITT: yes
Participants	Country: Turkey 20 participants (10 in EXP group, 10 in CTL group) Ambulatory at study onset: yes Mean age: 62 years (CTL and EXP groups respectively) Inclusion criteria: ischaemic or haemorrhagic stroke prior 6 weeks to study enrolment, confirmed by MRI, MMSE score > 21, supported or independent 1‐minute free‐standing, significant loss of ambulation (FAC < 3) Exclusion criteria: recurrent stroke interfering with the study, severe contractures of the lower extremity joints, severe cardiac conditions, uncontrolled diabetes mellitus, Parkinson's Disease, current thrombosis in the legs, aphasia, depression and body weight > 110 kg
Interventions	2 arms: CTL group used general physiotherapy, 5 times per week for 4 weeks (300 minutes a week) EXP group received BWSTT, 5 times per week for 4 weeks (300 minutes a week)
Outcomes	Outcomes were recorded at baseline, at the end of the intervention phase and at 3‐month follow‐up FAC, Rivermead Motor Evaluation Gross (RMD1) and total gross function (RMD2), Berg Balance Scale, Barthel Index, walking capacity (6‐Minute Walk Test), walking speed (10 metre walk), cadence rate, ratios of right‐left step length, muscle activity (EMG)
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not reported
Allocation concealment (selection bias)	Unclear risk	Not reported
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not reported